Shield Therapeutics Share Discussion Threads

[eastlands] 28/5/2021 14:21

Large order being filled?

[oapknob1] 28/5/2021 14:18

All those trades showing as buys and nada movement !!!!

[donaferentes] 28/5/2021 14:11

Thanks kalkaar - always nice to hear a bit of corroboration.

[amaretto1] 28/5/2021 13:51

Very impressive !!Even half her target

[kalkaar] 28/5/2021 13:34

from Dr. Susie Jana, Healthcare Analyst at Edison:

Pharma & biotech - Mcap £123m - Price 57p - Flash note

Greg Madison succeeds Tim Watts as CEO:

Shield Therapeutics (STX) has announced the appointment of a new chief executive officer (CEO), Greg Madison, with effect from 1 June 2021. Greg is a seasoned CEO with previous experience of the US iron deficiency market. Notably, he led the transformation of Keryx Biopharmaceuticals (2015–18) into a US commercial stage company focused on Auryxia (ferric citrate), an oral product for the treatment of iron deficiency anaemia and hyperphosphatemia. Given the primary focus for STX now is to establish and expand its US-based operations ahead of a Q221 launch of lead asset Accrufer (oral ferric maltol), the appointment of a US-based CEO makes sense in our view. Our valuation of STX is unchanged at £505.7m or 234p/share.

[base7] 28/5/2021 10:49

Great news that we have a sales team in the US under the direction of a US based ceo with a strong track record to lead growth .Increased my holding by 50% at almost double my lowest purchase price

[babbler] 28/5/2021 08:52

They've had 3 chances lol. But eventually yes they will be replaced by buyers.

[kalkaar] 28/5/2021 08:52

the real coup was getting Brian Groch - changed everything for Shield imho.. he's got us set-up and good to go in the US in no time whatsoever.. i have no doubt he has also been instrumental in getting the new CEO on board..

UK company run by yanks targeting the yank market with proven experience.. what's not to like?

Hopefully they won't be a pushover in negotiations to further the reach of Ferracru in Europe too - haven't maximised the potential in Europe by any stretch!

but all focus on the US market short term.. if they nail this 150p will be considered cheap make no mistake!

[purchaseatthetop] 28/5/2021 08:47

Babbler....do not worry. The news shareholders will sell and then later today the new buyers will drive it up to 65p today.

PATTtrueforecast.

[tradertrev] 28/5/2021 08:47

Given 60p is double the recent placing price, bound to be a profit-taking / top-slicing level for some.

[babbler] 28/5/2021 08:45

This just can't hold 60p... What will it take ffs? Early days...

[daveboy19] 28/5/2021 08:43

Finally, the jigsaw is fitting together. This is the centre piece imho, just a year late, but better late than never. Jerry's 44p now looking (thankfully) a distant bad dream. Full steam ahead.

[purchaseatthetop] 28/5/2021 08:41

*gasps*

baddogrex1 has gone native!!!! Wild and crazy guy.

[baddogrex1] 28/5/2021 08:36

This is very good news in fact all the recent News releases have been very positive for the company
I have changed my view and have thrown caution to the wind and increased my holding by 20% this morning.
You are allowed to change your mind on this board are you not?
Buy Buy Buy by by

[purchaseatthetop] 28/5/2021 08:35

Combine the new CEO with our two new NEDs and we have a really strong US delivery team. Really I am both impressed and a bit surprised (happily)

[someuwin] 28/5/2021 08:35

finnCap:

"Shield Therapeutics (STX): Corp

CEO appointment

Shield announced that Greg Madison has been appointed as Chief Executive Officer with effect from 1 June 2021. He has extensive experience and a good track commercialisation track record in the US iron deficiency market. With Accrufer on track to be launched in the US by the end of June, this appointment should reduce further the execution risk in our view. We reiterate our target price of 250p, which is based on a rNPV model over the life of Accrufer’s patent."

[weatherman] 28/5/2021 08:26

Very positive- this should reduce the execution risk, and lead to a re-rating imo.

[parob] 28/5/2021 08:15

Let's see if we can get a close above 60p today. That would be bullish.Then onwards to that gap.

[con90210] 28/5/2021 08:15

Was thinking that yesterday actually that STX must be a target for a takeover especially at the low price currently.

[kalkaar] 28/5/2021 08:09

hear hear - the limitations of TW were plain to see

especially happy to see someone appointed super fast and with pedigree

wouldn't be surprised to see STX taken out at some point next year

[kemche] 28/5/2021 08:02

Addresses one of the issues that some had. Onwards.

[toffeeman] 28/5/2021 07:57

Huge relief to see Tim go - hope Handjob goes as well!

[rimau1] 28/5/2021 07:44

At last, an oven ready CEO to execute the strategy after years of tripping over our own shoe laces. The recent pumpers and prophets will be noisy today but i might actually have a top up to celebrate.

[frrinvest] 28/5/2021 07:43

TW was always a wrong man in the wrong job but good luck to him in the future. A new CEO indeed is a great news.